JLJanet Lee

Janet Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Janet Lee has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    User-centered design of digital audit and feedback dashboards to support pediatric antimicrobial stewardship

    by Dina Abdel-Rahman, Praveena Korakuti, Erin K. Tagai, Janet Lee

    Background: Audit and feedback (A&F) is commonly used to support guideline-concordant care, yet its effectiveness varies widely and is strongly influenced by how feedback is designed and experienced by clinicians. Poorly designed A&F can be perceived as punitive, unclear, or disconnected from clinical workflows, limiting engagement and impact. User-centered design (UCD) approaches offer a promising strategy to optimize A&F interventions prior to large-scale implementation. This study describes the application of UCD combined with rapid assessment procedures (RAP) to iteratively develop audit and feedback dashboards to support pediatric antimicrobial stewardship. Methods: We conducted a qualitative, iterative design study within a large urban health system as part of a broader antimicrobial stewardship implementation initiative. Using RAP, we completed four interview waves with clinicians ( N = 16) from pediatrics, family and community medicine, internal medicine, and emergency medicine. Semi-structured interviews explored general attitudes toward performance metrics and detailed feedback on successive departmental and individual A&F dashboard mock-ups. Data were rapidly synthesized using matrix analysis, with team-based debriefs between waves to identify themes and guide iterative dashboard refinements until thematic saturation was achieved. Results: Early dashboard versions were described as visually dense, difficult to interpret, and insufficiently transparent regarding metric definitions and calculation methods. Clinician concerns evolved across iterative design cycles, shifting from readability and visual design to credibility of metrics, perceived fairness, psychological safety, and workflow integration. Participants emphasized the importance of actionable feedback, appropriate peer comparators, transparency balanced with simplicity, opportunities for discussion and reflection, and alignment with clinical workflows and decision support tools. By the final interview wave, clinicians generally viewed the dashboards as clear, acceptable, and supportive of reflection, learning, and quality improvement. Conclusions: Applying user-centered design and rapid assessment methods prior to implementation can meaningfully improve the readability, acceptability, and perceived credibility of audit and feedback interventions. Findings suggest that effective A&F should be intentionally designed as a collaborative learning tool rather than a compliance mechanism. Early, iterative engagement with clinicians may be critical to fostering trust, engagement, and sustained behavior change in stewardship and other implementation science efforts.

  • Open Access

    Optimizing Clinical Decision Support for Antibiotic Prescribing in Pediatric Acute Respiratory Tract Infections: A Usability Study

    by Janet Lee, Dina Abdel-Rahman, Emma Kelly, Praveena Korakuti, Erin Tagai

    Background: Inappropriate antibiotic prescribing contributes to antimicrobial resistance. Antimicrobial stewardship (AMS) programs increasingly rely on electronic health record (EHR)–based clinical decision support (CDS) alerts to guide evidence-based care, yet poorly designed alerts can increase cognitive burden and contribute to burnout. Usability testing offers a structured approach to improving alert design and adoption. Objective: To evaluate and iteratively refine interruptive CDS alerts developed to support appropriate antibiotic prescribing for pediatric acute respiratory tract infections (ARTIs) within an urban academic health system as part of a larger implementation project. Methods: Twelve providers participated in four waves of virtual usability testing using scripted clinical scenarios reflecting common workflows. Participants interacted with three clinical alerts and one design focused scenario. Quantitative outcomes included task effectiveness, efficiency, satisfaction, and perceived difficulty. Qualitative feedback was gathered via think aloud techniques and synthesized using a “rainbow spreadsheet.” Iterative modifications were implemented between waves until thematic saturation was achieved. Results: Task completion across scenarios was high (83.3%). Effectiveness and efficiency improved over waves, and satisfaction increased when alerts embedded actionable tasks such as ordering tests, adding diagnoses, or switching antibiotics. Participants emphasized the importance of clear, concise text, and intuitive defaults. Including links to evidence-based guidelines improved trust. Alert refinements reduced cognitive load and improved workflow alignment. Conclusions: Rapid, iterative usability testing substantially improved the clarity and workflow integration of interruptive CDS alerts. Incorporating usability evaluation into CDS stewardship efforts can enhance adoption, reduce alert fatigue, and strengthen implementation of evidence-based practices.

  • From Re--ations to Practice: The Evolution of Suicide Prevention Strategies in Pediatric Settings

    by Cori M. Green, Alexandra Huttle, Janet Lee, Maria H. Rahmandar


  • Open Access

    Associations Between Eating Disorders and Sociodemographic Factors in Adolescent Patients Since the Start of the COVID-19 Pandemic

    by Janet Lee, David Miller, Paulina Rugart

    Background/Objectives: The COVID-19 pandemic has been associated with significant increases in mental-health-related concerns in adolescents, including eating disorders. Disparities in screening, diagnosis, and treatment impact adolescents with eating disorders. This study aimed to describe the patterns in the prevalence and the associations between eating disorder diagnoses and demographic factors in adolescent patients since the start of the COVID-19 pandemic. Methods: We performed a retrospective cohort study examining adolescent patients (aged 12 to 21) with an eating disorder (ED) diagnosis documented between January 2019 and July 2023 using Epic Systems Corporation’s Cosmos, a de-identified dataset aggregated from electronic health record (EHR) data. We examined the differences in demographic factors by utilizing chi-square and Kruskal–Wallis rank sum tests. Results: A total of 82,435 distinct adolescent and young adult patients with eating disorder diagnoses were included in the analytical dataset. The overall prevalence of EDs has increased since 2019. The median age of patients with an ED decreased between 2019 and 2023. There was a decrease in other eating disorder diagnoses and an increase in avoidant-restrictive food intake disorder (ARFID) during the study period. There was a decrease in the proportion of individuals who identified as White and an increase in the proportion of adolescents from historically minoritized racial and ethnic groups (i.e., African American or Black and Hispanic). There was also an increase, during this study period, in the proportion of adolescents with an ED diagnosis who were from more socially vulnerable communities. Conclusions: Our study describes the changes in the prevalence of sociodemographic factors in adolescent patients with EDs since the start of the COVID-19 pandemic. Further studies should address screening, diagnostic, and treatment barriers for EDs in historically underserved communities.


  • Open Access

    Health Disparities in Hospitalized Pediatric Patients with Autism Spectrum Disorder and COVID-19

    by Janet Lee, Lisa Ferretti, Camden Nelson, Priya Nigam, Jessica Zawacki, Philip McCallion

    Background/Objectives: Pediatric patients with autism spectrum disorder (ASD) face unique challenges, especially amongst individuals from historically minoritized racial groups. ASD has also been associated with an increased mortality from COVID-19. This study aims to explore the differences in sociodemographic factors and health outcomes (as measured by length of stay) amongst hospitalized pediatric patients with COVID-19 infections and a diagnosis of ASD compared to individuals with a COVID-19 infection alone; Methods: We performed a retrospective cohort study examining pediatric patients (ages birth to 21) who were hospitalized with a diagnosis of ASD and COVID-19 compared to patients with a diagnosis of COVID-19 alone between January 2019 and June 2023 using Epic Systems Corporation’s Cosmos, a de-identified dataset aggregated from electronic health record data. We examined differences in demographic factors and length of stay (LOS) between groups by utilizing chi-square and Wilcoxon rank sum tests. Multiple logistic regression models were utilized to assess the association between length of stay and diagnosis; Results: A total of 21,708 distinct pediatric patients with a diagnosis of ASD and COVID-19 or COVID-19 alone were included in the analytical dataset. Patients with ASD and COVID-19, compared to patients with COVID-19 alone, had a higher proportion of individuals identifying as male and White. Patients with COVID-19 alone, compared to individuals with ASD and COVID-19, had higher proportions of individuals identifying as Black or African American. Higher proportions of individuals with ASD and COVID-19 had public insurance, compared to individuals with COVID-19 alone. Having a diagnosis of ASD and COVID, after controlling for covariates, was associated with higher odds of having a length of stay greater than the three days (cutoff value determined by the median LOS of three days) compared to having a diagnosis of COVID alone (aOR 1.19, 95% CI 1.04–1.35); Conclusions: Our study highlights the health disparities experienced during hospitalizations by pediatric patients with ASD and COVID-19. Further studies should address barriers and support health outcomes for pediatric patients with ASD.